Elisabet Londos
61 – 70 of 152
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Increased CSF biomarkers of angiogenesis in Parkinson disease.
(
- Contribution to journal › Article
-
Mark
Various outcomes of cholinesterase inhibitor treatment influence survival of patients with Alzheimer’s disease.
2015) 12th International Conference on Alzheimer`s and Parkinson`s Diseases (AD/PD 2015)(
- Contribution to conference › Poster
-
Mark
A Diagnostic Model for Dementia in Clinical Practice-Case Methodology Assisting Dementia Diagnosis.
(
- Contribution to journal › Article
-
Mark
Various measures of progression predicting mortality in Alzheimer’s disease.
2015) Alzheimer’s Association International Conference (AAIC), 2015 In Alzheimer's & Dementia 11(7 Suppl.). p.293-294(
- Contribution to journal › Published meeting abstract
- 2014
-
Mark
Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study.
(
- Contribution to journal › Article
-
Mark
Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Kynurenic Acid levels in cerebrospinal fluid from patients with Alzheimer's disease or dementia with lewy bodies.
(
- Contribution to journal › Article
-
Mark
Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services.
(
- Contribution to journal › Article
-
Mark
Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of Dementia with Lewy Bodies.
(
- Contribution to journal › Article